These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 19171001

  • 21. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E, Culibrk B, Gyöngyössy-Issa MI, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV.
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of pooled cultures for bacterial detection in whole blood-derived platelets.
    Ramirez-Arcos S, Goldman M.
    Transfusion; 2005 Aug; 45(8):1275-9. PubMed ID: 16078912
    [Abstract] [Full Text] [Related]

  • 31. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
    Dumont LJ, Gulliksson H, van der Meer PF, Murphy S, Nixon JG, de Wildt-Eggen J, Vandenbroeke T, Aubuchon JP.
    Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J, Haager B, Krex D, Zimmermann R, Strasser E, Antoon M, De Schrijver E, Eckstein R.
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers.
    AuBuchon JP, Taylor H, Holme S, Nelson E.
    Transfusion; 2005 Aug; 45(8):1356-61. PubMed ID: 16078926
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of the in vitro properties of apheresis platelets during 7-day storage after interrupting agitation for one or three periods.
    Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.
    Transfusion; 2008 Dec; 48(12):2492-500. PubMed ID: 18764829
    [Abstract] [Full Text] [Related]

  • 40. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG, SPRINT Study Group.
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.